Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1

Biochemical Pharmacology
Iskandar IdrisRichard Donnelly

Abstract

The insulinotropic agent, exendin-4, is a long-acting analogue of glucagon-like peptide-1 (GLP-1) which improves glucose tolerance in humans and animals with diabetes, but the underlying mechanisms and the effects of exendin-4 on peripheral (muscle/fat) insulin action are unclear. Previous in vivo and clinical studies have been difficult to interpret because of complex, simultaneous changes in insulin and glucagon levels and possible effects on hepatic metabolism. Thus, the comparative effects of exendin-4 and GLP-1 on insulin-stimulated 2-[3H]deoxyglucose (2-DOG) uptake were measured in fully differentiated L6 myotubes and 3T3-adipocytes, including co-incubation with inhibitors of the PI-3-kinase (wortmannin) and mitogen-activated protein (MAP) kinase (PD098059) pathways. In L6 myotubes, there was a concentration-dependent and PI-3-kinase-dependent increase in insulin-stimulated 2-DOG uptake with exendin-4 and GLP-1, e.g. for exendin-4 the C(I-200) value (concentration of insulin required to increase 2-DOG uptake 2-fold) decreased from 1.3 +/- 1.4 x 10(-7)M (insulin alone, n=16) to 5.9 +/- 1.3 x 10(-8)M (insulin+exendin-4 0.1nM, n=18, P<0.03). A similar insulin-sensitizing effect was observed with exendin-4 in 3T3-adipocytes, ...Continue Reading

References

May 1, 1997·Archives of Biochemistry and Biophysics·A I AlcántaraM L Villanueva-Peñacarrillo
Sep 1, 1997·Journal of Cellular Physiology·C Montrose-RafizadehL G Adams
Sep 9, 1998·The American Journal of Physiology·H YangC Montrose-Rafizadeh

❮ Previous
Next ❯

Citations

Dec 7, 2002·Diabetes/metabolism Research and Reviews·Jens Juul Holst
Jun 4, 2011·Breast Cancer Research and Treatment·Hagai LigumskyTami Rubinek
Dec 25, 2003·Trends in Endocrinology and Metabolism : TEM·Irina A UrusovaRiccardo Perfetti
Sep 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susan L SamsonLawrence Chan
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Jul 30, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Dominique DardevetAlan D Cherrington
Oct 23, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Elisabeth L RaabRebecca A Simmons
Aug 13, 2010·Critical Care : the Official Journal of the Critical Care Forum·Gabriel A MecottMarc G Jeschke
Nov 20, 2013·Annual Review of Physiology·Young Min ChoTimothy J Kieffer
Jun 4, 2013·Archives of Physiology and Biochemistry·A CignarelliR Vettor
Oct 24, 2014·Diabetes·Achint KaurMichael R Hayden
Dec 5, 2015·Diabetes, Obesity & Metabolism·Marcel H A MuskietDaniël H van Raalte
Sep 13, 2011·Progress in Biophysics and Molecular Biology·Jae-Hyung ParkDae-Kyu Song
Nov 10, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Laurie L Baggio, Daniel J Drucker
Sep 25, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Güzin Fidan-YaylalıLevent Elmas
Jul 31, 2016·Journal of Translational Medicine·Francesco AndreozziFranco Folli
Mar 18, 2004·American Journal of Physiology. Endocrinology and Metabolism·D DardevetA D Cherrington
Apr 25, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Mark M SmitsErik H Serné
Jun 16, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Weihao WangPei Yu
Nov 8, 2005·The Journal of Biological Chemistry·Sunmin ParkMorris F White
Aug 9, 2018·Pharmacological Reviews·T D MüllerM H Tschöp
Oct 12, 2007·Physiological Reviews·Jens Juul Holst
Jul 25, 2019·International Journal of Molecular Sciences·Ismael González-GarcíaCristina Contreras
Aug 21, 2020·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Daniela Rosendo-Silva, Paulo Matafome
Jul 17, 2018·The Prostate·Wenjing He, Junhe Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.